Cystoscope Market Size, Share, Opportunities, And Trends By Type (Rigid Cystoscope, Flexible Cystoscope), By Applications (Urology, Gynaecology), By End-User (Hospitals, Ambulatory Surgical Centres), And By Geography - Forecasts From 2025 To 2030
- Published : May 2025
- Report Code : KSI061611601
- Pages : 145
Cystoscope Market Size:
The Cystoscope Market is expected to grow from US$294.223 million in 2025 to US$375.455 million in 2030, at a CAGR of 5.00%.
A cystoscope is a thin, telescope-like tube with a light and tiny camera attached instrument used to perform a cystoscopy, also known as cystourethroscopy that allows a physician to examine and treat the lower urinary tract (urethra, prostate, bladder neck, and bladder). The cystoscope is inserted into the bladder through the urethra for the evaluation, treatment, or diagnosis of the conditions such as Bladder cancer, haematuria, frequent urinary tract infections (UTIs), Urinary blockage, Urinary stones, etc. making cystoscopy procedures one of the most commonly performed procedures in the urology office settings. Major companies have been providing novel and advanced solutions for their customers. For instance, Ambu, one of the largest suppliers of innovative and advanced single-use endoscopes, would be providing solutions for urology, in the coming years. The company had announced that it would launch a novel single-use, sterile, and high-resolution cystoscope in the year 2022. The company had also stated that they would launch a novel and single-use digital flexible ureteroscope in the year 2022. These trends and developments are expected to play a major role in the market growth, during the forecast period.
Cystoscope Market Growth Driver:
- Rising incidences of urinary tract diseases boost the market.
The growth in the global cystoscope market may be attributed to the rising prevalence of urinary tract diseases globally. As per the data from the National Kidney Foundation, there are approximately 10 million doctor visits for urinary tract infections in the US. Similar rising incidences of other diseases such as prostate cancer, stones, bladder cancer, etc. will also boost the market during the given time frame. As per Cancer Research UK, prostate cancer is the most common cancer in men with around 47,700 new prostate cancer cases in the UK every year. However, complications such as infections, bleeding, and swollen urethra that may arise during cystoscopy procedures might restrain the growth of the market during the forecast period. According to a journal published in the United States National Library of Medicine National Institutes of Health, urinary tract infections are one of the most common infections, with an average lifetime incidence of 50-60% in most adult women. Urinary tract infections are some of the most common infections in the United States. The prevalence in women over 65 years is around 20%, compared with around 11% of the overall population. Moreover, there are around 258,000 cases of pyelonephritis in the United States, per year, with a higher and bigger frequency among females. In women, who are aged between 18-49 years, the total approximate incidence of pyelonephritis is around 28/10,000. These trends are expected to accelerate the demand for novel cystoscope devices and applications, in the coming years.
Cystoscope Market Geographical Outlook:
- The Asia Pacific has a major share.
The market is expected to surge in the region due to the rising cases of urinary infections and prostate cancer. In India, according to the Indian Council of Medical Research, the incidence rate of prostate cancer in the country had been around 9-10/per 100,000 population, which is comparatively higher as compared to countries in Asia and Africa. In China, according to the National Cancer Registration Institute, prostate cancer has been the most common tumor in the male urinary system since the year 2008. These trends are expected to accelerate the demand for novel and advanced cystoscope products and systems.
Cystoscope Market Scope:
| Report Metric | Details |
| Cystoscope Market Size in 2025 | US$294.223 million |
| Cystoscope Market Size in 2030 | US$375.455 million |
| Growth Rate | CAGR of 5.00% |
| Study Period | 2020 to 2030 |
| Historical Data | 2020 to 2023 |
| Base Year | 2024 |
| Forecast Period | 2025 – 2030 |
| Forecast Unit (Value) | USD Million |
| Segmentation |
|
| Geographical Segmentation | North America, South America, Europe, Middle East and Africa, Asia Pacific |
| List of Major Companies in Cystoscope Market |
|
| Customization Scope | Free report customization with purchase |
The cystoscope market is analyzed into the following segments:
- By Type
- Rigid Cystoscope
- Flexible Cystoscope
- By Applications
- Urology
- Gynecology
- By End-User
- Hospitals
- Ambulatory Surgical Centers
- By Geography
- North America
- USA
- Canadá
- Mexico
- South America
- Brazil
- Argentina
- Others
- Europe
- UK
- Germany
- France
- Italy
- Others
- Middle East and Africa
- Asia Pacific
- Japan
- China
- India
- South Korea
- Thailand
- Taiwan
- Indonesia
- Others
- North America
Frequently Asked Questions (FAQs)
The cystoscope market is expected to reach a total market size of US$375.455 million by 2030.
Cystoscope Market is valued at US$294.223 million in 2025.
The cystoscope market is expected to grow at a CAGR of 5.00% during the forecast period.
The Asia Pacific region is anticipated to hold a significant share of the cystoscope market.
Prominent key market players in the cystoscope market include Karl Storz, NeoScope Inc., Coloplast Group, Cogentix Medical, Henke-Sass Wolf, Advanced Health Care Resources, among others.
1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
5. CYSTOSCOPE MARKET BY TYPE
5.1. Introduction
5.2. Rigid Cystoscope
5.3. Flexible Cystoscope
6. CYSTOSCOPE MARKET BY REUSABILITY
6.1. Introduction
6.2. By Reusability
6.3. Reusable Cystoscopes
6.4. Disposable Cystoscopes
7. CYSTOSCOPE MARKET BY TECHNOLOGY
7.1. Introduction
7.2. Standard Imaging
7.3. High-Definition (HD) Imaging
7.4. Narrow-Band Imaging
8. CYSTOSCOPE MARKET BY APPLICATION
8.1. Introduction
8.2. Urology
8.3. Gynaecology
8.4. Oncology
8.5. Research
9. CYSTOSCOPE MARKET BY END-USER
9.1. Introduction
9.2. Hospitals
9.3. Ambulatory Surgical Centers
9.4. Urology Clinics
9.5. Diagnostic Centers
10. CYSTOSCOPE MARKET BY GEOGRAPHY
10.1. Introduction
10.2. North America
10.2.1. By Type
10.2.2. By Reusability
10.2.3. By Technology
10.2.4. By Application
10.2.5. By End-User
10.2.6. By Country
10.2.6.1. USA
10.2.6.2. Canada
10.2.6.3. Mexico
10.3. South America
10.3.1. By Type
10.3.2. By Reusability
10.3.3. By Technology
10.3.4. By Application
10.3.5. By End-User
10.3.6. By Country
10.3.6.1. Brazil
10.3.6.2. Argentina
10.3.6.3. Others
10.4. Europe
10.4.1. By Type
10.4.2. By Reusability
10.4.3. By Technology
10.4.4. By Application
10.4.5. By End-User
10.4.6. By Country
10.4.6.1. United Kingdom
10.4.6.2. Germany
10.4.6.3. France
10.4.6.4. Spain
10.4.6.5. Others
10.5. Middle East and Africa
10.5.1. By Type
10.5.2. By Reusability
10.5.3. By Technology
10.5.4. By Application
10.5.5. By End-User
10.5.6. By Country
10.5.6.1. Saudi Arabia
10.5.6.2. UAE
10.5.6.3. Others
10.6. Asia Pacific
10.6.1. By Type
10.6.2. By Reusability
10.6.3. By Technology
10.6.4. By Application
10.6.5. By End-User
10.6.6. By Country
10.6.6.1. China
10.6.6.2. Japan
10.6.6.3. India
10.6.6.4. South Korea
10.6.6.5. Taiwan
10.6.6.6. Others
11. COMPETITIVE ENVIRONMENT AND ANALYSIS
11.1. Major Players and Strategy Analysis
11.2. Market Share Analysis
11.3. Mergers, Acquisitions, Agreements, and Collaborations
11.4. Competitive Dashboard
12. COMPANY PROFILES
12.1. Stryker Corporation
12.2. PENTAX Medical
12.3. Olympus Medical Corporation
12.4. Richard Wolf GmbH
12.5. Karl Storz SE & Co. KG
12.6. NeoScope Inc.
12.7. Coloplast Group
12.8. Cogentix Medical Inc. (Laborie)
12.9. Henke-Sass Wolf
12.10. Ambu A/S
12.11. Boston Scientific Corporation
12.12. Laborie Medical Technologies, Inc.
13. APPENDIX
13.1. Currency
13.2. Assumptions
13.3. Base and Forecast Years Timeline
13.4. Key Benefits for the Stakeholders
13.5. Research Methodology
13.6. Abbreviations
Stryker Corporation
PENTAX Medical
Olympus Medical Corporation
Richard Wolf GmbH
Karl Storz SE & Co. KG
NeoScope Inc.
Coloplast Group
Cogentix Medical Inc. (Laborie)
Henke-Sass Wolf
Ambu A/S
Boston Scientific Corporation
Laborie Medical Technologies, Inc.
Related Reports
| Report Name | Published Month | Download Sample |
|---|---|---|
| Endoscopy Devices Market Size & Forecast 2025-2030 | Free Sample | May 2025 | |
| Angioscope Device Market Insights: Share, Trends, Forecast 2030 | May 2025 | |
| Capsule Endoscopy Market Trends, Forecast 2025-2030 | Free Sample | May 2025 | |
| Endoscopes Market Size, Share & Forecast 2025-2030 | Free Sample | Jan 2025 |
